Savella and Hydroxyzine hydrochloride drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Savella (milnacipran hydrochloride) and Hydroxyzine hydrochloride (hydroxyzine hydrochloride). Common drug interactions include dry eye among females and anxiety disorder among males.

The phase IV clinical study analyzes what interactions people have when they take Savella and Hydroxyzine hydrochloride. It is created by eHealthMe based on reports of 24 people who take the same drugs from the FDA, and is updated regularly.

What is Savella?

Savella has active ingredients of milnacipran hydrochloride. It is often used in fibromyalgia. eHealthMe is studying from 7,529 Savella users. Check the latest studies of Savella.

What is Hydroxyzine hydrochloride?

Hydroxyzine hydrochloride has active ingredients of hydroxyzine hydrochloride. It is often used in stress and anxiety. eHealthMe is studying from 10,486 Hydroxyzine hydrochloride users. Check the latest studies of Hydroxyzine hydrochloride.



On Jul, 09, 2026

24 people who take Savella and Hydroxyzine hydrochloride together, and have interactions are studied.

Savella and Hydroxyzine hydrochloride drug interactions.

What are the common drug interactions of Savella and Hydroxyzine Hydrochloride, by gender? *:

female:

  1. Dry eye (lack of adequate tears)
  2. Inflammation
  3. Nausea (feeling of having an urge to vomit)
  4. Pain in extremity
  5. Dizziness
  6. Drug ineffective
  7. Injury
  8. Intervertebral disc protrusion (spinal disc protrusion)
  9. Staphylococcal infection (an infection with staphylococcus bacteria)
  10. Back pain

male:

  1. Anxiety disorder
  2. Dizziness
  3. Dyspnoea (difficult or laboured respiration)
  4. Feeling drunk
  5. Hypervigilance
  6. Skin burning sensation
  7. Skin tightness
  8. Somnolence (a state of near-sleep, a strong desire for sleep)
  9. Vertigo

What are the common drug interactions of Savella and Hydroxyzine Hydrochloride, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Angioedema (rapid swelling of the dermis)
  2. Aphthous ulcer (mouth ulcer)
  3. Bone pain
  4. Headache (pain in head)
  5. Kidney infection
  6. Nausea (feeling of having an urge to vomit)
  7. Oral discomfort (pain or irritation in mouth)
  8. Pain in extremity
  9. Abnormal behaviour
  10. Allergy to metals

30-39:

n/a

40-49:

  1. Dry eye (lack of adequate tears)
  2. Age-related macular degeneration
  3. Arthralgia (joint pain)
  4. Back pain
  5. Bone erosion
  6. Hypoaesthesia (reduced sense of touch or sensation)
  7. Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development)
  8. Joint crepitation
  9. Joint stiffness
  10. Joint warmth

50-59:

  1. Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect)
  2. Renal failure (kidney dysfunction)
  3. Surgery
  4. Angioedema (rapid swelling of the dermis)
  5. Drug hypersensitivity
  6. Chronic kidney disease
  7. Drug ineffective
  8. Joint swelling
  9. Osteoarthritis (a joint disease caused by cartilage loss in a joint)

60+:

  1. Age-related macular degeneration
  2. Retinal pigmentation (pigmentation of retina)
  3. Chronic kidney disease
  4. Renal failure (kidney dysfunction)

What are the existing conditions these people have? *

  1. Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 7 people, 29.17%
  2. Muscle Spasms (muscle contraction): 6 people, 25.00%
  3. Cataplexy (loss of muscle tone accompanied by full conscious awareness): 5 people, 20.83%
  4. Multiple Allergies (allergy to multiple agents): 4 people, 16.67%
  5. Cystitis Interstitial (unknown cause characterized by bladder pain): 4 people, 16.67%
  6. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 4 people, 16.67%
  7. Back Pain: 4 people, 16.67%
  8. Sleep Disorder: 4 people, 16.67%
  9. Restless Leg Syndrome (a powerful urge to move your legs): 4 people, 16.67%
  10. Raynaud's Phenomenon (discoloration of the fingers, toes, and occasionally other areas): 3 people, 12.50%

* Approximation only. Some reports may have incomplete information.

Do you take Savella and Hydroxyzine hydrochloride?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Savella and Hydroxyzine hydrochloride:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Savella:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Hydroxyzine hydrochloride:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Savella and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Hydroxyzine hydrochloride and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on milnacipran hydrochloride and hydroxyzine hydrochloride (the active ingredients of Savella and Hydroxyzine hydrochloride, respectively), and Savella and Hydroxyzine hydrochloride (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: